55
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at Exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's Lymphoma in Japanese

, , , , , , , , & show all
Pages 957-964 | Received 03 Oct 2003, Published online: 03 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pranami Bhaumik, Priyanka Ghosh, Atanu Biswas, Sujay Ghosh, Sandip Pal, Biswanath Sarkar & Subrata Kumar Dey. (2017) Rare Intronic Variations in TP73 Gene Found in Patients with Alzheimer’s Disease. International Journal of Human Genetics 17:4, pages 158-168.
Read now
Karin Ekström-Smedby. (2006) Epidemiology and etiology of non-Hodgkin lymphoma – a review. Acta Oncologica 45:3, pages 258-271.
Read now

Articles from other publishers (21)

Sarah Jafrin, Md. Abdul Aziz & Mohammad Safiqul Islam. (2022) Association between TP73 G4C14-A4T14 polymorphism and different cancer types: an updated meta-analysis of 55 case–control studies . Journal of International Medical Research 50:10, pages 030006052211331.
Crossref
Jialin Meng, Shuo Wang, Meng Zhang, Song Fan, Li Zhang & Chaozhao Liang. (2018) TP73 G4C14-A4T14 polymorphism and cancer susceptibility: evidence from 36 case–control studies. Bioscience Reports 38:6.
Crossref
Yalu Liu, Xiaogan Wang, Ning Ding, Lan Mi, Lingyan Ping, Xuan Jin, Jiao Li, Yan Xie, Zhitao Ying, Weiping Liu, Chen Zhang, Lijuan Deng, Yuqin Song & Jun Zhu. (2017) TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP. BMC Cancer 17:1.
Crossref
Yasuki Hori, Katsuyuki Miyabe, Michihiro Yoshida, Takahiro Nakazawa, Kazuki Hayashi, Itaru Naitoh, Shuya Shimizu, Hiromu Kondo, Yuji Nishi, Shuichiro Umemura, Akihisa Kato, Hirotaka Ohara, Hiroshi Inagaki & Takashi Joh. (2015) Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma. PLOS ONE 10:3, pages e0118829.
Crossref
L. Michael Carastro, Hui-Yi Lin, Hyun Y. Park, Donghwa Kim, Selina Radlein, Kaia K. Hampton, Ardeshir Hakam, Babu Zachariah, Julio Pow-Sang & Jong Y. Park. (2014) Role of p73 Dinucleotide Polymorphism in Prostate Cancer and p73 Protein Isoform Balance . Prostate Cancer 2014, pages 1-9.
Crossref
E. De Feo, B. Simone, R. S. Kamgaing, P. Galli, N. Hamajima, Z. Hu, G. Li, Y. Li, K. Matsuo, J. Y. Park, S. Roychoudhury, M. R. Spitz, Q. Wei, J.-H. Zhang, W. Ricciardi & S. Boccia. (2011) p73 G4C14-to-A4T14 gene polymorphism and interaction with p53 exon 4 Arg72Pro on cancer susceptibility: a meta-analysis of the literature. Mutagenesis 27:3, pages 267-273.
Crossref
Zijun Y. Xu-MonetteL. Jeffrey MedeirosYong LiRobert Z. Orlowski, Michael Andreeff, Carlos E. Bueso-RamosTimothy C. Greiner, Timothy J. McDonnellKen H. Young. (2012) Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies. Blood 119:16, pages 3668-3683.
Crossref
Yi HuLan JiangJian ZhengYonghe YouYifeng ZhouShunchang Jiao. (2012) Association Between the p73 Exon 2 G4C14-to-A4T14 Polymorphism and Cancer Risk: A Meta-Analysis . DNA and Cell Biology 31:2, pages 230-237.
Crossref
Lan Wang, Rui Gao & Long Yu. (2011) Combined analysis of the association between p73 G4C14-to-A4T14 polymorphisms and cancer risk. Molecular Biology Reports 39:2, pages 1731-1738.
Crossref
Xiao-Jia Yu, Fang Fang & Jun Xie. (2011) Relationship between TP73 polymorphism (G4C14–A4T14) and cancer risk: A meta-analysis based on literatures. Gene 484:1-2, pages 42-46.
Crossref
Ondrej Havranek, Martin Spacek, Petr Hubacek, Heidi Mocikova, Katerina Benesova, Pavel Soucek, Marek Trneny & Zdenek Kleibl. (2011) No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphoma. Leukemia Research 35:8, pages 1117-1119.
Crossref
F. Liu, L. Liu, B. Li, Y.-G. Wei, L.-N. Yan, T.-F. Wen, M.-Q. Xu, W.-T. Wang & J.-Y. Yang. (2011) p73 G4C14-A4T14 polymorphism and cancer risk: a meta-analysis based on 27 case-control studies. Mutagenesis 26:4, pages 573-581.
Crossref
F. Liu, B. Li, Y. Wei, X. Chen, Y. Ma, L. Yan & T. Wen. (2011) P21 codon 31 polymorphism associated with cancer among white people: evidence from a meta-analysis involving 78 074 subjects. Mutagenesis 26:4, pages 513-521.
Crossref
Ya Li, Fei Liu, Shiqiao Tan & Shangwei Li. (2011) P21 Ser31Arg Polymorphism and Cervical Cancer Risk. International Journal of Gynecological Cancer 21:3, pages 445-451.
Crossref
Hee Nam Kim, Li Yu, Nan Young Kim, Il‐Kwon Lee, Yeo‐Kyeoung Kim, Deok‐Hwan Yang, Je‐Jung Lee, Min–Ho Shin, Kyeong‐Soo Park, Jin‐Su Choi & Hyeoung‐Joon Kim. (2010) Association with TP53 codon 72 polymorphism and the risk of non‐Hodgkin lymphoma . American Journal of Hematology 85:10, pages 822-824.
Crossref
Jinyun Chen, Donghui Li, Ann M. Killary, Subrata Sen, Christopher I. Amos, Douglas B. Evans, James L. Abbruzzese & Marsha L. Frazier. (2008) Polymorphisms of p16, p27, p73, and MDM2 Modulate Response and Survival of Pancreatic Cancer Patients Treated with Preoperative Chemoradiation. Annals of Surgical Oncology 16:2, pages 431-439.
Crossref
Todd G. Nick & Kathleen M. Campbell. 2007. Topics in Biostatistics. Topics in Biostatistics 273 301 .
A Pluta, U Nyman, B Joseph, T Robak, B Zhivotovsky & P Smolewski. (2006) The role of p73 in hematological malignancies. Leukemia 20:5, pages 757-766.
Crossref
Matthew B. Schabath, Xifeng Wu, Qingyi Wei, Guojun Li, Jian Gu & Margaret R. Spitz. (2006) Combined Effects of the p53 and p73 Polymorphisms on Lung Cancer Risk . Cancer Epidemiology, Biomarkers & Prevention 15:1, pages 158-161.
Crossref
Guojun Li, Zhensheng Liu, Erich M. Sturgis, Qiuling Shi, Robert M. Chamberlain, Margaret R. Spitz & Qingyi Wei. (2005) Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis 26:9, pages 1596-1602.
Crossref
Xiaoxian Li, Patrick Dumont, Anthony Della Pietra, Cory Shetler & Maureen E. Murphy. (2005) The Codon 47 Polymorphism in p53 Is Functionally Significant. Journal of Biological Chemistry 280:25, pages 24245-24251.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.